General Announcement :: Accrelist Doubles Capacity at SingPost Center Medical Esthetics Clinic

10 Ubi Crescent, Ubi Techpark Lobby E,

# 03-94 Singapore 408564

Phone: (65) 6311 2900

Fax: (65) 6311 2905

For immediate release

Accrelist doubles the capacity of its aesthetic medical clinic to

SingPost Center

Dr Terence Tea, Executive Chairman and CEO of Accrelist,

at the opening of the SingPost Center of AM Aesthetics.

Singapore, September 23, 2021 – Accrelist Ltd. (????) (“Accrelist“, the “Society“, and

with its subsidiaries, the “Group“) opened its SingPost Center clinic at 10 Eunos Road 8, # 02-140 / 141, SingPost Center, moving into a larger 2-unit space in the mall, to meet growing customer demand and offer improved customer experience.

The modernized clinic has 10 treatment rooms, more than double its previous capacity, reflecting the Group’s confidence in the long-term prospects of its medico-aesthetic activity.

Accrelist Medical Esthetics (“AM Aesthetics“) first acquired a chain of four local clinics in 2018, including the SingPost Center clinic. Under the leadership of Accrelist Executive Chairman and CEO, Dr. Terence Tea, AM Aesthetics has grown into a network of seven clinics local across Singapore and three overseas branches in Malaysia.

Page 1 of 3

Dr Terence Tea said: ‘Despite the challenges of COVID-19, we continue to build on our track record

for the growth of the Group’s medico-aesthetic segment. In addition to adding more clinics to our network,

we also regularly expand existing clinics to enable us to serve more clients. ”

The clinic at Bedok Mall is also expected to move to a larger space within the mall by the end of October 2021.

The Group also continues to develop its clinical skin care products business through AM Skincare Pte.

Ltd. (“AM Skin Care“) to broaden its source of income.

AM Aesthetics generated sales of S $ 6.3 million for the fiscal year ended March 31, 2021 (“FY2021“), an increase of S $ 1.3 million or 26.0% from S $ 5.0 million for the year ended 31

March 2020 (“FY2020“).

The Group is pursuing its plans to expand its medico-aesthetic segment with a measured approach for sustainable growth.

-To finish-

About Accrelist Ltd. (????)

Accrelist Ltd. (“Accrelist“) seeks to create long-term value for our shareholders and business partners by unleashing and adding value to the companies in which we invest. The Group continues to actively seek new opportunities with an increasing emphasis on medical aesthetics.

The group’s wholly owned subsidiaries include the Accrelist Medical Aesthetics group of companies, under the brand AM Aesthetics, and AM Skincare Pte. Ltd. (“AM Skin Care“).

AM Aesthetics operates a chain of registered aesthetic medical clinics in Singapore and Malaysia that use state of the art equipment and clinically proven solutions to provide a wide range of highly reliable and effective treatments.

AM Skincare is primarily engaged in the retail sale of pharmaceutical and medical products. It develops and distributes its own original design manufacturer clinical skin care products (“ODM“) with the support of South Korean dermatologists alongside other non-ODM products.

In addition, Accrelist owns a majority stake of 53.07% in Jubilee Industries Holdings Ltd. (“Jubilee“), a one-stop-shop service provider with two main lines of business:

  1. Mechanical Business Unit (“MBU“) which is primarily engaged in precision plastic injection molding and mold design and manufacturing services; and
  2. Electronics Business Unit (“EBU“) which distributes integrated electronic components.

Headquartered in Singapore, Jubilee’s production facilities span across Malaysia and Indonesia. Jubilee’s products are sold to customers in Singapore, Malaysia, Indonesia, Vietnam, India, People’s Republic of China, United States and various European countries.

For more information, please visit

Page 2 of 3

Issued on behalf of Accrelist Ltd.

By RHT Communications and Investor Relations Pte Ltd

For media inquiries, please contact:

Elliot Siow

Communication manager

RHT Communications and Investor Relations Pte. Ltd.

Did: +65 6381 6347

E-mail: [email protected]

This press release has been reviewed by the limited partner of the company, RHT Capital Pte. Ltd. (“Sponsor“), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (“SGX-STThe Sponsor has not independently verified the contents of this press release.

This press release has not been reviewed or approved by SGX-ST and SGX-ST assumes no responsibility for the contents of this press release, including the accuracy of any statements or opinions made or reports contained. in this press release.

The contact person for the sponsor is: –

Name: Mr. Mah How Soon, Registered Professional, RHT Capital Pte. Ltd.

Address: 6 Raffles Quay, # 24-02, Singapore 048580 [email protected]

Page 3 of 3


Accrelist Ltd. published this content on September 23, 2021 and is solely responsible for the information it contains. Distributed by Public, unedited and unmodified, on September 23, 2021 11:51:08 AM UTC.

Previous FreedomPlus personal loans 2021 review - Forbes Advisor
Next Interview: we find out why Dislyte is Lilith Games' most ambitious title to date